Kuros Biosciences AG/ CH0325814116 /
9/10/2024 5:13:18 PM | Chg. +0.21 | Volume | Bid5:20:00 PM | Ask5:20:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
18.10CHF | +1.17% | 4,227 Turnover: 76,230.12 |
-Bid Size: - | -Ask Size: - | 658.84 mill.CHF | - | - |
Assets
2012 IFRS in mill. CHF |
2013 IFRS in mill. CHF |
2014 IFRS in mill. CHF |
2015 IFRS in mill. CHF |
2016 IFRS in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | .1000 | .1000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Intangible Assets | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 6.6000 | ||||||
Long-Term Investments | .1000 | .1000 | .1000 | 0.0000 | 0.0000 | ||||||
Fixed Assets | .2000 | .2000 | .1000 | 0.0000 | 30.4000 | ||||||
Inventories | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Accounts Receivable | - | - | - | - | - | ||||||
Cash and Cash Equivalents | 28.6000 | 39.8000 | 16.9000 | 15.9000 | 12.4000 | ||||||
Current Assets | 30.2000 | 40.3000 | 17.6000 | 16.2000 | 13.4000 | ||||||
Total Assets | 30.4000 | 40.5000 | 17.6000 | 16.2000 | 43.8000 |
Liabilities
2012 IFRS in mill. CHF |
2013 IFRS in mill. CHF |
2014 IFRS in mill. CHF |
2015 IFRS in mill. CHF |
2016 IFRS in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | .4000 | 1.5000 | .2000 | 1 | 1.3000 | ||||||
Long-term debt | 13.9000 | 27.5000 | - | - | - | ||||||
Liabilities to Banks | 13.9000 | 27.5000 | 42.5000 | 3.7000 | 0.0000 | ||||||
Provisions | 2.3000 | 2.5000 | .4000 | .4000 | 2 | ||||||
Liabilities | 20.4000 | 36.3000 | 43.9000 | 5.7000 | 5.4000 | ||||||
Share Capital | 2.2000 | 3.1000 | 3.1000 | 1.3000 | 5.1000 | ||||||
Total Equity | 10 | 4.2000 | -26.2000 | 10.4000 | 38.3000 | ||||||
Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Total liabilities equity | 30.4000 | 40.5000 | 17.6000 | 16.2000 | 43.8000 |
Income Statement
2012 IFRS in mill. CHF |
2013 IFRS in mill. CHF |
2014 IFRS in mill. CHF |
2015 IFRS in mill. CHF |
2016 IFRS in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1.1000 | 1 | 1 | .2000 | 1.1000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | -13.5000 | -23.3000 | -19.9000 | -4.2000 | -21.3000 | ||||||
Interest Income | - | - | - | - | - | ||||||
Income Before Taxes | -10.1000 | -30.8000 | -34 | -5.8000 | -20.3000 | ||||||
Income Taxes | .9000 | 0.0000 | 0.0000 | 0.0000 | .6000 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Net Income | -9.2000 | -30.8000 | -34 | -5.8000 | -19.7000 |
Per Share
Cash Flow
2012 IFRS in mill. CHF |
2013 IFRS in mill. CHF |
2014 IFRS in mill. CHF |
2015 IFRS in mill. CHF |
2016 IFRS in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -11.5000 | -19.2000 | -23.8000 | -2.6000 | -8.9000 | ||||||
Cash Flow from Investing Activities | 4 | .1000 | .6000 | 0.0000 | 1.8000 | ||||||
Cash Flow from Financing | 11.6000 | 30.1000 | .2000 | 17 | 3.5000 | ||||||
Decrease / Increase in Cash | 4.1000 | 11.1000 | -23 | 14.4000 | -3.6000 | ||||||
Employees | - | - | - | 4 | 16 |